Page Tools:
  • print-friendly version

Economic Evaluation in U.S. Health Care: Principles and Applications

Author(s): Laura T. Pizzi, PharmD, MPH, Jefferson Medical College
Jennifer Lofland, PharmD, MPH, PhD, Jefferson Medical College
Details:
  • ISBN-13: 9780763727468
  • ISBN-10:0763727466
  • Paperback    186 pages      © 2006
Price: International Sales $87.95 US List
Add to Cart Request a Review Copy

Overview

The steady flow of new pharmaceuticals and new technology has provided clinicians with an arsenal of effective treatments and diagnostic techniques. However, these interventions come at a price. With healthcare providers continuing to struggle with rising costs, clinical effectiveness alone will no longer be the only criteria for evaluating a drug or device. In the face of limited budgets, healthcare payers and providers will be expected to understand the value of new interventions in terms of economic, clinical, and quality of life benefits.

Based on the core principles of pharmacoeconomics, this text provides an overview of the methodologies that can be applied to both drug and non-drug interventions. Economic Evaluation in U.S. Health Care: Principles and Applications offers health professionals a solid foundation for understanding, interpreting, and applying the tools of economic evaluation and is essential for anyone involved in healthcare decision-making. 

ShowKey Features

Economic Evaluation of Health Care Interventions:

  • Focuses on pharmaceuticals as well as other health interventions
  • Covers the essentials of economic evaluation in a simple, concise format
  • Provides the perspectives of different stakeholders involved in the application of economic evaluation in the U.S., including manufacturers, health plans, and the government, in order to give the reader an understanding about how methods are applied to decision-making and health policy
  • Includes case studies to assist readers in applying methods to real-life situations 

Back to top

ShowTable of Contents

Foreword
Donald M. Steinwachs

Preface
David B. Nash

Chapter 1
An Overview of the Economic Evaluation of Healthcare Interventions
Sara Poston, Laura T. Pizzi, and Jennifer H. Lofland

Chapter 2
Measuring Economic Outcomes
Shreekant Parasuraman, Christopher Salvador, and Kevin D. Frick

Chapter 3
Health-Related Quality of Life and Utility
Christine Weston and Dong-Churl Suh

Chapter 4
Health – Related Productivity
Nikita Patel, Jennifer H. Lofland, and Laura T. Pizzi

Chapter 5
Adjustments within Economic Evaluation
Craig S. Roberts and Daniel Polsky


 

Chapter 6
The Industry’s Involvement in Economic Evaluation
Dennis Meletiche, Feride Frech, and Laura T. Pizzi

Chapter 7
Formulary Decision-Maker Perspectives: Responding to Changing Environments
Alan Lyles

Chapter 8
The U.S. Regulator’s Perspective in Determining and Improving the Value of Healthcare Interventions
Richard G. Stefanacci and Jennifer H. Lofland

Chapter 9
The Future of Economic Evaluation within the United States
David B. Nash

 

Index


Back to top

ShowAbout the Author(s)

Laura T. Pizzi, PharmD, MPH-Jefferson Medical College

Dr. Laura Pizzi is Associate Director of Research in the Department of Health Policy at Thomas Jefferson University. Dr. Pizzi received a Bachelor's degree in Pharmacy and a Doctor of Pharmacy degree from the Rutgers University College of Pharmacy in New Jersey, and was a fellow in pharmacoeconomics and outcomes research at the University of Pennsylvania Medical Center in Philadelphia, Pennsylvania. She obtained a Masters in Public Health in Epidemiology and Quantitative Methods from the New Jersey School of Public Health at the University of Medicine and Dentistry. Dr. Pizzi frequently writes and presents on topics related to economic evaluation in health care, and instructs the graduate course in economic evaluation at the Jefferson College of Graduate Studies. Dr. Pizzi's research interests are in the areas of economic evaluation, medication usage and policy, prescribing informatics, and health-related productivity. She resides in New Jersey with her husband and two children.

Jennifer Lofland, PharmD, MPH, PhD-Jefferson Medical College

Dr. Jennifer Lofland is a Project Director and Research Assistant Professor in the Department of Health Policy at Thomas Jefferson University. She obtained her PharmD degree from the University of Maryland, and her MPH and PhD degrees from the Johns Hopkins Bloomberg School of Public Health in Baltimore.    She completed a residency in Pharmacy Practice at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania. Dr. Lofland’s research interests include health services research and health-related productivity. She has published numerous articles on the economics of migraine headache and is particularly interested in the impact of headache on one’s ability to work.  She resides in the Philadelphia area with her husband and two children.

Back to top

ShowReviews

  • "Authors Pizzi and Lofland have done a commendable job in addressing this controversial subject, drafting a text that is direct and certain in point-of-view and presentation. Accordingly, Economic Evaluation provides a comprehensive summary of the methods providers should use when evaluating economic factors in relation to assessment of treatment options for patients. Even though the text is 'based on core principles of pharmacoeconomics,' it nonetheless speaks to all facets of health care, with the writers' analysis applicable to both drug and non-drug therapies."


    —John Aiello
    The Electric Review
    December 2005

Back to top

ShowAppropriate Courses

Primary Course: Economic Evaluation of Health Care Interventions

Secondary Course: Clinical Research: From Policy to Practice

This course will be taught in Pharmacy Schools, specifically for Pharmacoeconomics classes that are typically required for Doctor of Pharmacy students, Public Health Schools or Masters of Public Health Programs with an Economic Evaluation elective, or in Medical Schools with an Economic Evaluation elective.

Back to top